Home CARDIO-DIABETIC ROSUBIS A 20/150
CARVIPURE 20 Back to CARDIO-DIABETIC ACAROSE 50
ROSUBIS A 20/150
LIVE_SCAN
QUALITY_SYSTEM: ACTIVE BATCH_VERIFIED: YES

ROSUBIS A 20/150

CAPSULE REF: ROSUBIS_A_20_150
MRP Discount Selling Price You Saved
₹ 103.12 0% ₹ 103.12 ₹ 0.00
Accepted files: PDF, JPG, PNG. Mandatory for regulatory records compliance.
PCODE 615
SALT COMPOSITION ROSUVASTATIN 20MG+ASPIRIN 150MG CAP
TYPE CAPSULE
PACKED IN ALU ALU
PACKING 10X10 CAP
THERAPEUTIC CARDIO/HYPERTENSIVE
MAIN CATEGORY Cardio-Diabetic
PARENT MANUFACTURER GENEXX

Product Overview

PHARMA INTEGRITY PROTOCOL

The Generic Advantage

Slide to visualize how artificial markups inflate branded medicine pricing, or compare the clinical facts below.

Interactive Cost Breakdown Simulator

Generic formulation Branded medicine
Direct Sourcing (Save up to 90%) Commercial Overhead & Markups
Active Ingredients & Mfg. ₹10
Estimated Patient Cost: ₹10
GENERIC_PROTOCOL_ACTIVE (100% Value)
RECOMMENDED PROTOCOL

Generic Medicines

₹10 avg. patient cost
  • ✓
    Active Ingredients: 100% Identical formula & strength
  • ✓
    Bioequivalence: Identical therapeutic effect & absorption
  • ✓
    Manufacturing: WHO-GMP / FDA Certified Plants
  • ✓
    Government Endorsed: PMBJP / Jan Aushadhi Approved
  • ✓
    Supply-Chain Savings: 80% to 90% Direct Sourced Discount
VS
RETAIL STANDARD

Branded Medicines

₹100 avg. patient cost
  • ✓
    Active Ingredients: 100% Identical formula & strength
  • ✓
    Bioequivalence: Identical therapeutic effect & absorption
  • ✓
    Manufacturing: WHO-GMP / FDA Certified Plants
  • ✗
    Commercial Markup: Up to 800% marketing & ad inflation
  • ✗
    Patient Burden: Full brand premium pricing
Understand B2C Ordering Protocols →

You may also like

Recently viewed products